Published January 1, 2017
| Version v1
Journal article
Open
A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer
Creators
- 1. Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey
- 2. Antalya Educ & Res Hosp, Dept Surg Gastroenterol, Antalya, Turkey
- 3. Izmir Univ Econ, Fac Med, Izmir, Turkey
- 4. Ankara Numune Training & Res Hosp, Dept Surg 5, Ankara, Turkey
- 5. Yuksek Ihtisas Training & Res Hosp, Dept Gastroenterol Surg, Ankara, Turkey
- 6. Chaim Sheba Med Ctr, Dept Gen & Oncol Surg Surg C, Tel Hashomer, Israel
- 7. Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
Description
Background: Prognostic biomarkers for cancer have the power to change the course of disease if they add value beyond known prognostic factors, if they can help shape treatment protocols, and if they are reliable. The aim of this study was to identify such biomarkers for colon cancer and to understand the molecular mechanisms leading to prognostic stratifications based on these biomarkers.
Files
bib-749a0ceb-d280-4614-8e18-eb0deb713ca1.txt
Files
(317 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:d712f1550312c3089af61767705311a0
|
317 Bytes | Preview Download |